Gene-Disorder Association · Article
Gene
MTHFRMethylenetetrahydrofolate Reductase
×
First reported
1991
Supporting publications
12
Manually curatedApproved treatment annotated
Association Review
In brief
The association between MTHFR (Methylenetetrahydrofolate Reductase) and Homocystinuria is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
1
Compounds
1
Trials
1of 36 via MTHFR compounds
Publications
12
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Homocystinuria
The disorder
8 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Interventions
Therapeutics
1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials
36 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
12 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
08
Provenance
References & sources
13 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access